Digoxin, Inotropes & Acute Heart Failure
An old woman starts seeing the world tinged yellow-green, feels sick, and her heartbeat turns erratic. The culprit isn't a new disease — it's a two-hundred-year-old heart drug, tipped into toxicity by nothing more than a low potassium level from her water pill. Digoxin is powerful, ancient, and unforgiving, and it's the perfect lens for the drugs that ease heart-failure SYMPTOMS — as opposed to the pillars that prolong life.
An elderly woman with heart failure and atrial fibrillation, stable for years on digoxin, becomes nauseated, confused, and complains that lights look yellow with halos around them. Her heart monitor shows a new irregular rhythm. Nobody changed her digoxin — but her diuretic quietly lowered her potassium, and low potassium supercharges digoxin's effect, pushing a therapeutic dose into toxicity. This one case teaches the whole drug: how it works, why its window is so narrow, and the electrolyte that makes or breaks it.
Symptom relief first: diuretics
Loop diuretics relieve the congestion of heart failure. The breathlessness and swollen legs of heart failure come from fluid backing up (congestion). Loop diuretics like furosemide (from the diuretics section) are the workhorse for this — they pull off the excess fluid, easing the symptoms quickly. But it's essential to know their limit: diuretics make patients FEEL better, but they don't prolong life the way the four pillars do. They treat the symptom (congestion), not the underlying disease, so they're used alongside the survival drugs, not instead of them.
Digoxin: the ancient inotrope
Digoxin, derived from the foxglove plant, does two useful things. It blocks the cell's sodium-potassium pump, which indirectly raises calcium inside heart cells, making them contract more forcefully (a positive inotrope). And it increases vagal tone, slowing conduction through the AV node — which helps CONTROL THE RATE in atrial fibrillation. So digoxin is used to ease symptoms in heart failure and to slow the heart in AF. But it improves symptoms, NOT survival, and it's a textbook narrow-therapeutic-index drug (recall drug monitoring). Toxicity brings nausea and vomiting, confusion, the classic yellow-green vision with halos, and dangerous arrhythmias. Crucially, LOW POTASSIUM worsens digoxin toxicity — which is why a patient on both digoxin and a potassium-wasting diuretic is a set-up for exactly the opening case.
Digoxin and potassium compete for the same pump. Digoxin works by blocking the sodium-potassium pump, and potassium binds that pump at the same site — so when potassium is LOW, more digoxin binds and its effect (and toxicity) surges. That's why hypokalaemia from diuretics is the classic trigger of digoxin toxicity, and why you keep potassium normal in any digoxin patient. Severe toxicity has a specific antidote: digoxin-specific antibody fragments (Digibind).
The powerful inotropes & acute heart failure
When the heart is failing acutely — a patient crashing in cardiogenic shock or acute pulmonary oedema — stronger, short-term inotropes are used intravenously in intensive care. Dobutamine stimulates beta-1 receptors to boost contractility (from the adrenergic section), and milrinone blocks an enzyme (PDE3) to raise cyclic AMP, both increasing force AND dilating vessels (an 'inodilator'). These are powerful rescue drugs, but they raise the heart's oxygen demand and, used long-term, actually shorten life — so they're reserved for short bursts in a crisis. For acute pulmonary oedema itself, the immediate management is to sit the patient up, give oxygen (or non-invasive ventilation), an intravenous loop diuretic, and nitrates to reduce the preload flooding the lungs.
- Loop diuretics relieve congestion (symptoms) but don't prolong life.
- Digoxin: blocks the Na/K pump → more contractility; ↑vagal tone → AV slowing (rate control in AF).
- Digoxin has a narrow window; toxicity = nausea, yellow-green vision, arrhythmias; worsened by LOW potassium.
- Digoxin antidote = digoxin-specific antibody (Digibind).
- IV inotropes (dobutamine, milrinone) rescue acute/shock states but harm if used long-term.
- Treating diuretics/digoxin as survival drugs. They relieve symptoms; the four pillars prolong life.
- Ignoring potassium in a digoxin patient. Low potassium triggers toxicity.
- Missing the yellow-green vision & nausea of digoxin toxicity in an unwell elderly patient.
- Using IV inotropes long-term. They increase oxygen demand and mortality — short-term only.
An elderly patient on digoxin and a loop diuretic develops nausea and yellow-tinged vision. The most likely trigger is:
- Loop diuretics relieve congestion symptoms but don't prolong life.
- Digoxin boosts contractility and slows the AV node (AF rate control); narrow window, symptom drug.
- Low potassium triggers digoxin toxicity (yellow vision, arrhythmias); antidote = Digibind.
- IV inotropes (dobutamine, milrinone) rescue acute shock but harm long-term.
- Katzung BG. Basic & Clinical Pharmacology — Drugs Used in Heart Failure (digoxin & inotropes).
- Brunton LL, et al. Goodman & Gilman's The Pharmacological Basis of Therapeutics — Cardiac glycosides & inotropic agents.
- Rang HP, Dale MM, et al. Rang & Dale's Pharmacology — Heart failure & cardiac glycosides.
- ACC/AHA & ESC Heart Failure Guidelines — Diuretics, digoxin & acute heart failure.
- Whalen K. Lippincott Illustrated Reviews: Pharmacology — Digoxin & inotropic drugs.
